Gürbüz, M. Et Al. 2021. Combination of trastuzumab and taxane-containing intensified chemotherapy in first-line treatment of HER2-positive advanced gastric cancer.. Tumori , vol.107, no.5 , 416-423.

Gürbüz, M., Akkuş, E., Sakin, A., Urvay, S., Demiray, A. G., Şahin, S., ... Şakalar, T.(2021). Combination of trastuzumab and taxane-containing intensified chemotherapy in first-line treatment of HER2-positive advanced gastric cancer.. Tumori , vol.107, no.5, 416-423.

Gürbüz, Mustafa Et Al. "Combination of trastuzumab and taxane-containing intensified chemotherapy in first-line treatment of HER2-positive advanced gastric cancer.," Tumori , vol.107, no.5, 416-423, 2021

Gürbüz, Mustafa Et Al. "Combination of trastuzumab and taxane-containing intensified chemotherapy in first-line treatment of HER2-positive advanced gastric cancer.." Tumori , vol.107, no.5, pp.416-423, 2021

Gürbüz, M. Et Al. (2021) . "Combination of trastuzumab and taxane-containing intensified chemotherapy in first-line treatment of HER2-positive advanced gastric cancer.." Tumori , vol.107, no.5, pp.416-423.

@article{article, author={Mustafa Gürbüz Et Al. }, title={Combination of trastuzumab and taxane-containing intensified chemotherapy in first-line treatment of HER2-positive advanced gastric cancer.}, journal={Tumori}, year=2021, pages={416-423} }